- Effect of benzo[a]pyrene treatment on hepatic cytochrrome P450 and NADPH: cytochrrome P450 reductase (POR) levels in mice with liver-specific deletion of the POR gene2007 | Faculty of Science
- Cytochromes P450 reconstituted with NADPH:P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes2006 | Faculty of Science
- Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome P450 reductase2003 | Faculty of Science
- Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization2011 | First Faculty of Medicine
- Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase2006 | First Faculty of Medicine
- Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase2006 | Faculty of Physical Education and Sport
- Diminished FAD-Binding Associated with Mutations of Human P450 ReductasePublication without faculty affiliation
- Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice2018 | Faculty of Science
- Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and P-32-postlabelling2012 | Faculty of Science
- Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome P450 reductase2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH: Cytochrome P450 reductase null mouse +12008 | Faculty of Science
- Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH : Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer2005 | Faculty of Science
- Kinetics of ellipticine oxidation by cytochromes P450 1A1 and 1A2 reconstituted with NADPH:cytochrome P450 reductase2007 | Faculty of Science
- Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype2016 | First Faculty of Medicine
- O2 metabolism by soluble cytochrome P450 reductase and its chimeras with C-termini of nitric oxide synthases assayed by diacetyldeuteroheme HRPPublication without faculty affiliation
- Pyruvate: ferredoxin oxidoreductase/NAD(P)H cytochrome P450 reductase reductase fusion in Cryptosporidium parvum - a novel target for drug design?2000 | First Faculty of Medicine
- Cloning and Characterization of a Pyruvate: Ferredoxin Oxidoreductase/NADPH Cytochrome P450 Reductase Fusion Gene from the Apicomplexan Cryptosporidium parvumPublication without faculty affiliation
- Cloning and charakterization of pyruvate: ferredoxin oxidoreductase/NADPH cytochtomr P450 reductase fusion gene from apicomlexan Cryptosporidium parvumPublication without faculty affiliation
- Isolation of plant cytochrome P450 and NADPH: cytochrome P450 reductase from tulip bulbs (Tulipa fosteriana L.) oxidizing xenobiotics1994 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine2019 | Faculty of Science
- Effect of Hepatic Cytochrome P450 (P450) Oxidoreductase Deficiency on 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine- DNA Adduct Formation in P450 Reductase Conditional Null Mice2011 | Faculty of Science
- Studies with the hepatic NADPH:cytochrome P450 reductase null mouse reveal the role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine2007 | Faculty of Science
- Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice2008 | Faculty of Science
- To the mechanism of 2-nitroanisole carcinogenicity: cytochrome P450-mediated metabolism of 2-nitroanisole2002 | Faculty of Science
- Metabolism of carcinogenic 2-nitroanisole by cytochromes P450 a nd reductases2001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Human cytochromes P450 1A1/2 and NADPH:cytochrom P450 reductase activate carcinogenic aristolochic acid to form DNA adducts found in patients with Chinese herbs nephropathy2003 | Faculty of Science
- Human cytochromes P450 1A1/2 and NADPH:cytochrom P450 reductase activate carcinogenic aristolochic acid to form DNA adducts found in patients with Chinese herbs nephropathy2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model2011 | Second Faculty of Medicine